000 01353 a2200409 4500
005 20250512023423.0
264 0 _c19870410
008 198704s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(87)90250-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVague, P
245 0 0 _aNicotinamide may extend remission phase in insulin-dependent diabetes.
_h[electronic resource]
260 _bLancet (London, England)
_cMar 1987
300 _a619-20 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsulin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aNiacinamide
_xadministration & dosage
650 0 4 _aRemission Induction
650 0 4 _aTime Factors
700 1 _aVialettes, B
700 1 _aLassmann-Vague, V
700 1 _aVallo, J J
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8533
_gp. 619-20
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(87)90250-9
_zAvailable from publisher's website
999 _c2886992
_d2886992